on INNATE PHARMA (EPA:IPH)
Innate Pharma announces a conference on its half-year results
Innate Pharma, listed on Euronext Paris and Nasdaq, will hold a conference call on September 17, 2026. This event, scheduled for 2:00 p.m. CEST, will aim to present the company's financial results and business for the first half of 2026.
The presentation, led by Jonathan Dickinson and three other executives, will be accessible via webcast and conference call, links to which are available on the company's website. This broadcast will be archived for 90 days.
Innate Pharma, located in Marseille, is dedicated to the development of immunotherapies for cancer. Its portfolio includes the development of therapeutic antibodies, as well as several projects in partnership with companies such as Sobi and AstraZeneca.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INNATE PHARMA news